Evidence map›Paper›PMID 42107403›Full record

ArticleBiologicals : journal of the International Association of Biological Standardization2026

Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting report.

Laurence de Moerlooze, Alexander Allen, Ilaria Bartalesi, Marco Cavaleri, Miles P Davenport, Bradford D Gessner, Brenda Gomes, Kyla Hayford, Alane Izu, Hector S Izurieta and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biologicals : journal of the International Association of Biological Standardization, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Laurence de MoerloozeP95, Leuven, Belgium.
Alexander AllenField Epidemiology and Health Protection Units, Public Health England, London, UK.
Ilaria BartalesiGSK, Siena, Italy.
Marco CavaleriEMA, Amsterdam, Netherlands.
Miles P DavenportInfection Analytics Program, Kirby Institute, UNSW Sydney, Kensington, NSW, 2052, Australia.
Bradford D GessnerEpiVac Consulting, Anchorage, AK, USA.
Brenda GomesBrazilian Health Regulatory Agency (ANVISA), Brasilia, Brazil.
Kyla HayfordVaccine Medical Affairs, Pfizer, Inc., New York, NY, USA.
Alane IzuSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa.
Hector S IzurietaOffice of Vaccines Research and Review, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, USA.
Victoria A JenkinsBavarian Nordic Belgium, Brussels, Belgium.
Randee KastnerTakeda Pharmaceuticals International AG, Zurich, Switzerland.
Phil KrauseBethesda, MD, USA.
Joshua NealonSanofi, Lyon, France.
Lidia OostvogelsMinervaX ApS, Frederiksberg, Denmark.
Arto A PalmuFVR - Finnish Vaccine Research, Tampere, Finland.
Robert C ReadNIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Carla SaenzDepartment of Evidence and Intelligence for Action in Health, Pan American Health Organization, Washington, DC, USA.
Dean K SmithIABS North America, Canada.
Suely TuboiTakeda Pharmaceuticals Brazil, São Paulo, Brazil.
Frank VandendriesscheFicaja Farma, Huldenberg, Belgium.
Marc BaayP95, Leuven, Belgium.
Danielle CraigCoalition for Epidemic Preparedness Innovations, P.O. BOX 123, Torshov, 0412, Oslo, Norway.
Pieter NeelsIABS, Geneva, Switzerland. Electronic address: pieter.neels@vaccine-advice.be.
Kaatje BollaertP95, Leuven, Belgium. Electronic address: kaatje.bollaerts@p-95.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42107403
PMCPMC13537031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.